Nanoco Group PLC

Dr Mark Carnegie-Brown Glide Pharma, an Oxford, UK-based pharma and device company focused on the needle-free administration of solid dose formulations, has appointed Dr Mark Carnegie-Brown CEO. Dr Ca

The news that a company is conducting a strategic review has grandiose implications of high-flying investment bankers, consultants and board members scouring the world and the management literature fo

The recent outpouring of soul searching, introspection and discussion prompted by the parting editorial from Greg Smith, a now ex-Goldman Sachs investment banker, has had little linkage to the biotech

Three of Europe's top financiers outline what European biotechs need to do to raise private funds and survive in the continually challenging funding environment. By Melanie Senior The top 25 health ca